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Abstract
 
In normal human serum (NHS), axenic promastigotes of 
 
Crithidia
 
, 
 
Phytomonas
 
, and 
 
Leishmania
 
trigger complement activation, and from 1.2 to 1.8 
 
 
 
 10
 
5
 
 C3 molecules are deposited per pro-
mastigote within 2.5 min. In 
 
Leishmania
 
, promastigote C3 binding capacity remains constant
during in vitro metacyclogenesis. C3 deposition on promastigotes activated through the classi-
cal complement pathway reaches a 50% maximum after 
 
 
 
50 s, and represents 
 
 
 
85% of total
C3 bound. In C1q- and C2-deficient human sera, promastigotes cannot activate the classical
pathway (CP) unless purified C1q or C2 factors, respectively, are supplemented, demonstrating
a requirement for CP factor in promastigote C3 opsonization. NHS depleted of natural anti-
 
Leishmania
 
 antibodies cannot trigger promastigote CP activation, but IgM addition restores C3
binding. Furthermore, 
 
Leishmania
 
 binds natural antibodies in ethylenediaminetetracetic acid
(EDTA)-treated NHS; after EDTA removal, promastigote-bound IgM triggers C3 deposition
in natural antibody-depleted NHS. Serum collectins and pentraxins thus do not participate
significantly in NHS promastigote C3 opsonization. Real-time kinetic analysis of promastigote
CP-mediated lysis indicates that between 85–95% of parasites are killed within 2.5 min of serum
 
contact. These data indicate that successful 
 
Leishmania
 
 infection in man must immediately follow
 
promastigote transmission, and that 
 
Leishmania
 
 evasion strategies are shaped by the selective
pressure exerted by complement.
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Introduction
 
Leishmania
 
 protozoa, the etiologic agents of the leishmani-
oses, are transmitted to vertebrate hosts by the bite of sand-
flies of the genera 
 
Phlebotomus
 
 (Old World) and 
 
Lutzomyia
 
(New World). Phlebotomine sandflies infect mammals by
inoculating promastigotes into hemorrhagic spots created
in the skin while probing for a blood meal. In contact with
normal human blood, 
 
Leishmania
 
 promastigotes trigger
complement activation and C3 opsonization (1). Analysis of
early promastigote–host cell interactions using an ex vivo
model of 
 
Leishmania
 
 human blood infection indicates that
after C3 opsonization, promastigotes undergo an immune
 
adherence (IA)
 
*
 
 reaction and bind to CR1 erythrocyte re-
ceptors (2). Further studies showed that 
 
Leishmania
 
-platelet
 
binding, a primitive form of 
 
Leishmania
 
-erythrocyte IA,
occurs after promastigote contact with blood of nonpri-
mate mammals, confirming that promastigote IA is the first
 
Leishmania
 
 interaction with mammalian cells after infection
(3). The immune adherent promastigotes are thereafter en-
docytosed by blood phagocytes, and undergo physiological
 
and phenotypic transformations inside the phagolysosomes,
which culminate in the vertebrate-dwelling amastigote
forms (4).
During 
 
Leishmania
 
 host invasion, complement-mediated
promastigote killing can compromise parasite survival.
Identification of promastigote opsonization by host serum is
thus essential to understanding 
 
Leishmania
 
 infection strategy.
Pioneering studies on promastigote opsonization in normal
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Abbreviations used in this paper:
 
 Ads-NHS, adsorbed NHS; AP, alterna-
tive complement pathway; C1qDS, serum deficient in C1q complement
component; C2DS, serum deficient in C2 complement factor; CP, classical
complement pathway; CRP, C-reactive protein; IA, immune adherence;
IRF, immune reactive fraction; MBL, mannan-binding lectin; NAb, nat-
ural antibody; PI, propidium iodide. 
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Leishmania
 
 Opsonization in Human Serum
 
human serum (NHS) indicated that IgM anti-
 
Leishmania
 
antibodies were responsible for promastigote agglutination,
classical complement pathway (CP) activation, and parasite
killing (5, 6). Despite these data, understanding of the pro-
mastigote opsonization mechanism has to date been domi-
nated by the concept that 
 
Leishmania
 
 spp. promastigotes
activate complement in NHS through the alternative path-
way (AP), thus lacking antibody involvement (7–9). Ex-
ceptions to this rule have been reported for 
 
Leishmania
donovani
 
 promastigotes (8) and axenic metacyclic peanut
agglutinin-negative forms of 
 
Leishmania major 
 
(10), but the
view prevails that leishmanias activate complement via the
AP (11, 12).
In addition to promastigote-C3 opsonization by the clas-
sical and alternative routes, it is also reported that two
specific carbohydrate-binding proteins in serum, mannan-
binding lectin (MBL) and the acute phase protein C-reac-
tive protein (CRP), bind 
 
Leishmania
 
 parasites (13–15); they
thus could initiate promastigote opsonization through a
novel antibody- and C1-independent mechanism, the lec-
tin-mediated pathway.
To clarify this issue, we performed a comprehensive
quantitative and kinetic analysis of promastigote opsoniza-
tion in NHS in near-physiological conditions using pro-
mastigote cell binding assays, high opsonizing serum con-
centrations (25–100%), and short incubation times (
 
 
 
3
min). The results indicate that binding of natural IgM anti-
 
Leishmania
 
 antibodies (NAb) to conserved trypanosomatid
epitopes triggers C3 parasite opsonization, and that serum
collectins (MBL) and pentraxins (CRP) do not participate
significantly in complement activation. In NHS, promas-
tigotes activate complement CP and AP simultaneously,
but 
 
 
 
85% of promastigote-bound C3 is generated through
the CP, indicating that physiological C3 opsonization of
 
Leishmania
 
 is activated through the CP in a natural infec-
tion. In the early infection period, promastigote lysis by
complement parallels the course of C3 deposition (2). As
real-time data on this mechanism were lacking, we mea-
sured real-time kinetics of promastigote killing in 50%
NHS, and show that from 85–95% of stationary culture
promastigotes become permeable to propidium iodide in
 
 
 
3 min after serum contact. Human infection by 
 
Leishma-
nia
 
 is thus an extremely rapid process, and promastigotes
must display evasion strategies immediately after inocula-
tion to avoid lysis by complement.
 
Materials and Methods
 
Parasites and Cultures.
 
Trypanosomatids studied were 
 
Leish-
mania donovani
 
 Khartoum 1246 (MHOM/SD/43/124), 
 
Leishma-
nia amazonensis 
 
Maria (MHOM/Br/79/Maria), 
 
Leishmania infan-
tum 
 
PB75 (MHOM/Fr/LEM75), 
 
L. major
 
 NIH 173 (MHOM/
IR/-/173), 
 
Crithidia
 
 
 
fasciculata
 
, and 
 
Phytomonas
 
 
 
characias
 
. 
 
Leishma-
nia
 
 and 
 
Crithidia
 
 promastigotes were cultured in RPMI 1640, and
 
Phytomonas
 
 in Grace’s medium (both from GIBCO BRL/Life
Technologies), supplemented with 10% heat-inactivated FCS
(Imperial Labs), 2 mM L-glutamine, 100 IU/ml penicillin, and
100 
 
 
 
g/ml streptomycin (complete medium). Cultures were in-
 
cubated at 26
 
 
 
C. Stationary phase parasites were harvested and
handled as described previously (2).
 
Antibodies and Human Sera.
 
Blood from healthy donors was
allowed to clot in siliconized glass tubes (20
 
 
 
C, 30 min), and se-
rum aliquots stored in liquid nitrogen. Clinical and genetic data
of sera from patients with hereditary deficiencies in complement
factors C1q (C1qDS) and C2 (C2DS) have been reported else-
where (16, 17). Anti–human C3
 
 
 
 chain mAb SIM27–49, IgG2b,
developed in our laboratory, was purified from mouse ascites
fluid by HiTrap-protein A treatment. NHS was adsorbed (Ads-
NHS) for 30 min on ice with 
 
L. donovani
 
 or 
 
L. amazonensis
 
 pro-
mastigotes at a ratio of 1 ml of 50% PBS-diluted NHS:10
 
9
 
 pel-
leted promastigotes. Ads-NHS was centrifuged (11,000 
 
g
 
, 3 min),
and the supernatant readsorbed in two additional cycles; finally,
serum was filtered through a 0.22-
 
 
 
m pore membrane to remove
aggregates and used in functional assays. IgM was isolated from
NHS by affinity chromatography on a protamine-Sepharose
CL4B column by end-over-end mixing of 20 ml 50% H
 
2
 
0-
diluted NHS with 10 ml packed protamine-Sepharose beads (4 h,
20
 
 
 
C). After incubation, the column was washed and eluted as
described (18). The IgM-enriched fraction was dialyzed against
PBS, filtered to remove aggregates, stored at 4
 
 
 
C, and used
within 24 h. NHS IgG was isolated on a HiTrap Protein G col-
umn (Amersham Pharmacia Biotech). Protein content was deter-
mined by BCA assay (19). SIM27–49 (25 
 
 
 
g) was labeled with 5
 
 
 
l of Na 
 
125
 
iodine (carrier-free, 105.36 mCi/ml; Dupont/NEN
Life Science Products) in iodogen (Pierce Chemical Co.)-coated
tubes as described (2). The [
 
125
 
I]SIM27–49 immune reactive frac-
tion (IRF) was measured by titrating a fixed, limiting amount of
radiolabeled antibody against increasing concentrations of NHS-
opsonized 
 
Leishmania
 
 promastigotes, until promastigote-bound
C3 epitopes greatly exceeded [
 
125
 
I]SIM27–49 paratopes. The an-
tibody IRF was calculated by direct linear plot (20).
 
Kinetics of Complement Activation by Leishmania, Crithidia, and
Phytomonas Promastigotes in NHS and Mg-EGTA-treated NHS.
 
50 
 
 
 
l of a 2 
 
 
 
 10
 
8
 
/ml promastigote suspension were mixed with
50 
 
 
 
l of 50% NHS or 50% NHS-adjusted to 10 mM EGTA, 7
mM MgCl
 
2
 
 (Mg-EGTA-NHS), and incubated for varying time
periods. The reaction was terminated by adding cold PBS con-
taining 2.5% FCS and 0.05% NaN
 
3 
 
(PFS) and the parasites
washed twice by centrifugation (11,000 
 
g
 
, 1 min). The cell pellet
was resuspended in 200 
 
 
 
l of PFS containing 2 
 
 
 
 10
 
5
 
 cpm of
[
 
125
 
I]SIM27–49 (specific activity 10
 
7 
 
cpm/
 
 
 
g) and incubated 1 h
on ice. Promastigotes were then washed twice by centrifugation
as above, and bound [
 
125
 
I]SIM27–49 cpm determined. A t
 
50
 
 in-
dex (time required for each species to reach 50% maximum C3
binding) was calculated from a plot of percent-normalized pro-
mastigote-C3 binding against incubation time.
 
Complement Activation by Leishmania in C1q- and C2-deficient
Sera.
 
Duplicate 50 
 
 
 
l samples of a 2 
 
 
 
 10
 
8
 
/ml 
 
L. donovani
 
 pro-
mastigote suspension were incubated at 37
 
 
 
C with 50 
 
 
 
l of 50%
diluted NHS, 50% diluted Mg-EGTA-treated NHS, C1qDS, or
C2DS, for 0, 0.5, 3, 5, 7, and 10 min. Conditions for 
 
L. amazon-
ensis
 
 assay were identical, but to compensate for activity loss dur-
ing long-term storage, C2DS was used at 60% concentration. Pu-
rified C1q (125 
 
 
 
g/ml) and C2 (47,500 CH50 units) were
supplemented. After incubation, assay conditions were as de-
scribed above for complement activation kinetics. Finally, bound
[
 
125
 
I]SIM27–49 cpm were determined.
 
Complement Activation by Leishmania in Ig-supplemented Ads-
NHS.
 
IgM and IgG preparations devoid of complement activity
were purified as described above. All IgM and IgG preparations
used showed promastigote binding 
 
 
 
100% of that observed for 
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25% NHS. 
 
L. donovani
 
 and 
 
L. amazonesis
 
 promastigote triggering
of complement activation was analyzed in a two-step C3 binding
assay. Pelleted 
 
L. donovani
 
 promastigotes (10
 
7
 
) were resuspended
in 100 
 
 
 
l of 25% NHS adjusted to 10 mM EDTA (NHS-
EDTA), purified IgM adjusted to 10 mM EDTA (IgM-EDTA),
or purified IgG adjusted to 10 mM EDTA (IgG-EDTA), and in-
cubated (37
 
 
 
C, 30 s). Promastigotes were then washed twice by
centrifugation (11,000 
 
g
 
, 1 min). Promastigote pellets preincu-
bated in NHS-EDTA were resuspended in 100 
 
 
 
l of 25% NHS
(positive control) or 25% 
 
L. donovani
 
 Ads-NHS; promastigotes
preincubated in IgM-EDTA or IgG-EDTA were resuspended in
100 
 
 
 
l of 25% of 
 
L. donovani
 
 Ads-NHS. Tubes were incubated (2
min, 37
 
 
 
C), followed by two centrifugation washes (11,000 
 
g
 
, 1
min). Promastigotes were resuspended in 0.2 ml PFS containing
2 
 
 
 
 10
 
5
 
 [
 
125
 
I]SIM27–49 cpm and incubated (1 h, on ice). After
two further washes, bound cpm were determined. Control samples
for classical and alternative complement pathway activation were
not preincubated. To study CP activation, 10
 
7
 
 pelleted 
 
L. donovani
 
promastigotes were resuspended in 100 
 
 
 
l of 25% NHS, 25% Mg-
EGTA-NHS (NHS-EGTA), 25% purified IgM, 25% purified IgG,
or 25% 
 
L. donovani
 
-Ads-NHS, and incubated (2 min, 37
 
 
 
C). For
AP activation, promastigotes were resuspended in 100 
 
 
 
l of 25%
NHS, 25% NHS-EGTA, or 25% 
 
L. donovani
 
-Ads-NHS, and incu-
bated (15 min, 37
 
 
 
C). Samples were washed twice by centrifuga-
tion, promastigotes resuspended in 0.2 ml of PFS containing 2 
 
 
 
10
 
5
 
 cpm [
 
125
 
I]SIM27–49, incubated 1 h on ice, and processed as
above. NHS complement activation by 
 
L. amazonensis
 
 was mea-
sured similarly using 
 
L. amazonensis
 
-Ads-NHS.
 
Quantitation of CP-activated Promastigote-C3 Binding during In
Vitro Metacyclogenesis.
 
Cultures were seeded with 10
 
5
 
 
 
L. ama-
zonensis
 
 promastigotes/ml and cultured (27
 
 
 
C, 17 d). Promas-
tigotes were sampled at days 3, 4, 5, 6, 7, 10, 11, 14, and 17,
washed twice by centrifugation in PBS, and opsonized (10
 
8
 
 pro-
mastigotes/ml in 25% PBS-diluted NHS) at 37
 
 
 
C for 2.5 min.
Promastigotes were washed, added to duplicate tubes at concen-
trations of 0.625, 1.25, 2.5, 5, and 10 
 
 
 
 10
 
6
 
, adjusted to 10
 
7
 
/0.1
ml with nonopsonized promastigotes, and incubated (2 h, 0
 
 
 
C)
with a limiting amount of [
 
125
 
I]SIM27–49. After incubation,
promastigotes were washed twice by centrifugation and
bound [
 
125
 
I]SIM27–49 cpm determined. Background cpm
([
 
125
 
I]SIM27–49 cpm bound to nonopsonized promastigotes)
were subtracted. A single lot of [
 
125
 
I]SIM27–49 (specific activ-
ity, 6 
 
 
 
 10
 
6
 
 cpm/
 
 
 
g) was used for all experiments. K
 
d
 
 values
were calculated by direct linear plot from data of three indepen-
dent cultures.
To measure CP-activated C3 binding to stationary promasti-
gotes of 
 
Leishmania
 
 and 
 
Crithidia
 
, parasites (10
 
8
 
 cells/ml) were in-
cubated in 25% PBS-diluted NHS (37
 
 
 
C, 3 min). The reaction
terminated by dilution with PFS (4
 
 
 
C), and C3-opsonized pro-
mastigotes washed twice by centrifugation (1,500 
 
g
 
, 15 min).
Two duplicate series of tubes containing 10
 
5
 
 and 2 
 
 
 
 10
 
5
 
 C3-
promastigotes were adjusted to 5 
 
 
 
 10
 
6
 
 promastigotes/tube with
nonopsonized promastigotes. A third series of control tubes con-
tained 5 
 
 
 
 10
 
6
 
 nonopsonized promastigotes. Leishmanias were
pelleted and resuspended in 0.2 ml PFS containing increasing
concentrations of [
 
125
 
I]SIM27–49, until a paratope/ligand ratio of
 
 
 
10 was obtained. Samples were incubated on ice to equilibrium
(
 
 
 
3 h). After reaction, parasites were washed twice by centrifu-
gation (11,000 
 
g
 
, 1 min) in PFS and C3-bound [
 
125
 
I]SIM27–49
determined. Functional [
 
125
 
I]SIM27–49 was calculated as input
cpm 
 
 
 
 IRF. SIM27–49 K
 
d
 
 and the number of C3 molecules/
promastigote were calculated by direct linear plot and Scatchard
analysis (21, 22).
 
Real-time Kinetics of Leishmania Promastigote Lysis in NHS.
 
Promastigote cultures of 
 
L. major
 
, 
 
L. amazonensis
 
, 
 
L. donovani
 
, and
 
L. infantum
 
 were seeded in triplicate at 10
 
6
 
 cells/ml, and cell
growth registered daily. Parasites were sampled at mid-log and
early stationary growth phase, i.e., 2 d after the end of log-phase
growth, and real-time promastigote lysis in 50% pooled NHS was
analyzed by measuring propidium iodide (PI) uptake by killed
promastigotes in a FACSCalibur™ flow cytometer (Becton
Dickinson). The reaction was initiated by addition of 100 
 
 
 
l of
undiluted 0.22 
 
 
 
m porefiltered NHS into a tube containing
10
 
5
 
 promastigotes, 2 
 
 
 
l PI (0.5 mg/ml; Sigma-Aldrich) and PBS
(200 
 
 
 
l final reaction volume), and incubated in a 37
 
 
 
C water-
bath during the data acquisition period. Promastigotes were iden-
tified and gated at a forward-angle light scatter versus side-angle
light scatter. PI emission was collected in the FL2 detector
through a 585/42 nm band pass filter. Detector amplification was
set to include untreated promastigotes (negative control) between
10
 
0
 
–10
 
1
 
 intensity. Promastigotes were acquired at a ratio of 250
events over a period of 204.8 s, with a data acquisition interval of
200 ms, and analyzed with CELLQuest™ software (Becton
Dickinson). Promastigote PI uptake kinetics was analyzed in a
FL2 versus time dot-plot divided into thirteen 15.98 s regions.
The percentage of promastigotes incorporating PI over incuba-
tion time was quantitated for each region as number of events
emitting PI fluorescence 
 
 
 
10
 
1
 
/total event number (PI emitting
plus nonemitting promastigotes). Controls included (a) maximum
cell lysis in promastigotes treated (30 min) with acetone:methanol
(1:1), (b) pooled NHS, and (c) nonspecific promastigote lysis in
10 mM EDTA-chelated 50% NHS.
 
Results
 
Kinetics of NHS Complement Activation by Trypanosomatid
Promastigotes.
 
Complement activation by trypanosmatids
was analyzed by measuring NHS C3 binding kinetics to
four 
 
Leishmania
 
 promastigote species, 
 
L. donovani
 
, 
 
L. ama-
zonensis
 
, 
 
L. infantum
 
, and 
 
L. major
 
, and to promastigotes of
two unrelated trypanosomatid genera, 
 
C. fasciculata
 
 and 
 
P.
characias
 
. In 25% PBS-diluted NHS, all trypanosomatids
studied activate the classical and alternative complement
pathways simultaneously. Promastigote-C3 binding via the
CP is very rapid, reaching maximum within 2 to 3 min;
longer incubations of up to 15 min do not increase CP C3
deposition (Fig. 1). For 
 
Leishmania
 
 promastigotes, the aver-
age time required to deposit 50% of total C3 bound
through the CP (CP
 
t
 
50
 
) is 
 
 
 
50 s (49.5 
 
 
 
 7 s), and 53 s for
all trypanosomatids analyzed. After CP blockade with Mg-
EGTA, promastigote-C3 binding kinetics follows a slower
course characteristic of the AP activation mechanism. Try-
panosomatid promastigotes differ in their AP activation ki-
netics. Plotting the percent-normalized promastigote-C3
binding against incubation time rendered a sigmoid curve
for each trypanosomatid species, from which an AP
 
t
 
50
 
 in-
dex was obtained. Promastigotes can be classified by the
AP
 
t
 
50
 
 index as rapid (
 
C. fasciculata
 
 and 
 
L. amazonensis
 
; AP
 
t
 
50
 
3–3.5 min), intermediate (L. major, P. characias, and L. in-
fantum; APt50 4.9–6.5 min), and slow (L. donovani; APt50
8.5 min) AP activators.
At CPt50, the amount of C3 deposited by the AP is at
most 13.7% of total C3 binding. The CP-activated C3454 Leishmania Opsonization in Human Serum
deposition rate on the promastigote surface is thus seven
times faster than that activated by the AP. This indicates
that promastigote C3 deposition by the CP is the func-
tionally relevant mechanism during parasite opsonization
in NHS.
Complement Activation Mechanism by Leishmania Promasti-
gotes in NHS. Complement activation by the CP is Ca2 
and Mg2  ion-dependent, whereas AP activation requires
only Mg2 . Differential Ca2  chelation in Mg-EGTA-
treated NHS thus permits identification of the activating
pathway (23). To confirm that rapid and slow promasti-
gote-C3 deposition kinetics in NHS are triggered by the CP
and the AP, respectively, the C3 binding rate to L. donovani
and L. amazonensis promastigotes in NHS or Mg-EGTA–
treated NHS was compared with that in sera of individuals
congenitally deficient in C1q or C2 early CP factors. L.
donovani is a very slow AP activator, allowing clear separa-
tion between the CP and AP C3 binding courses (Fig. 1
E). In NHS, C3 deposition on L. donovani promastigotes
reaches a plateau after  3 min (Fig. 2 A), whereas the C3
binding rate is slower in C1qDS and C2DS, similar to the
course followed in Mg-EGTA–treated NHS. After 3 min,
the percentage of promastigote-C3 binding in C1qDS and
C2DS is only 15.6 and 10.5%, respectively, of that ob-
served in NHS. In contrast, promastigotes incubated in
C1qDS and C2DS supplemented with purified C1q and
C2 factors, respectively, recover CP C3 binding kinetics
and deposit 70.5% (in C1q-supplemented C1qDS) and
72.4% (C2-supplemented C2DS) of total C3 bound in
NHS. L. amazonensis is a rapid AP-activating species, and
the course of CP and AP C3 binding are closer to each
other in time than in L. donovani (Fig. 1 D). Analysis of L.
amazonensis promastigote-C3 deposition kinetics in C2DS,
and after C2DS supplementation with C2 factor, shows re-
sults similar to those in L. donovani (Fig. 2 B). These data
indicate that irrespective of the species analyzed, Leishmania
promastigotes require early CP factor activity for rapid C3
binding kinetics in NHS.
Classical Complement Pathway Triggering by Natural Anti-
Leishmania Antibodies. IgM and IgG devoid of comple-
ment activity were isolated from NHS by affinity chroma-
tography on protamine-Sepharose, and HiTrap-protein G,
respectively. NHS depleted of CP-triggering activity was
prepared by adsorption with L. donovani or L. amazonensis
promastigotes (Ads-NHS), as described (Materials and
Methods). Promastigote activation of the CP was analyzed
using a two-stage incubation assay that measures CP C3
deposition within 2 min. IgM, IgG, and Ads-NHS prepa-
rations lack the ability to trigger CP C3 deposition on pro-
mastigotes (Table I); after longer incubation (10 min), Ads-
Figure 1. Kinetics of C3 deposition on trypanosomatid promastigotes in NHS. Promastigotes (107) were incubated at 37 C in 25% NHS or 10 mM
EGTA/7 mM MgCl2-treated NHS for 0, 0.5, 1, 2, 3, 4, 5, 7, 10, and 15 min. Parasites were then washed twice by centrifugation (11,000 g, 1 min) in
cold PFS, and promastigote-bound C3 measured with anti-human C3  mAb [125I]SIM27–49. C3 binding (mean of duplicate values) is expressed as a
percentage of the point of maximum antibody. ( ) CP-activated, ( ) AP-activated C3 deposition. (A) P. characias (3); (B) C. fasciculata (4); (C) L. major
(3); (D) L. amazonensis (4); (E) L: donovani (4); (F) L. infantum (3). In parenthesis, the number of experiments performed for each species.455 Dominguez et al.
NHS shows AP C3 deposition capacity (89.5% for L. ama-
zonensis and 66.3% for L. donovani) similar to that seen in
NHS-EGTA (86.5% for L. amazonensis and 47% for L.
donovani; not shown). Promastigotes preincubated with
NHS-EDTA or IgM-EDTA, conditions that prevent pro-
mastigote MBL and CRP binding, and subsequently incu-
bated with Ads-NHS, trigger CP C3 deposition. In con-
trast, promastigotes preincubated in IgG-EDTA contribute
only  18% of total C3 bound (Table I). All together, these
data indicate that in NHS, natural IgM anti-Leishmania an-
tibodies are the main triggering factor for CP activation by
promastigotes, and that serum MBL and CRP do not con-
tribute significantly to this process.
Quantitative Analysis of CP Promastigote-C3 Opsonization
during In Vitro Metacyclogenesis. It is believed that axenic
Leishmania cultures give rise to two developmental pro-
mastigote forms, log phase complement-sensitive and sta-
tionary phase complement-resistant (24–28). The question
arises whether these differences in Leishmania susceptibility
to complement can be ascribed to variation in the CP ac-
tivating capacity of promastigote developmental stages.
We thus measured CP C3 deposition on L. amazonensis
promastigotes taken from different growth phases of in
vitro metacyclogenesis. Promastigotes were sampled daily
from triplicate cultures, and each sample individually op-
sonized in 25% NHS. Promastigote-bound C3 was ti-
trated against [125I]SIM 27–49, and Kd values of the C3-
opsonized promastigote populations calculated. Kd values
(the number of C3-opsonized promastigotes that bind
50% of [125I]SIM 27–49 cpm) are very similar, 1.0  
0.07   106 promastigotes/ml (mean   SEM), irrespective
of the culture growth phase. Differential susceptibility of
axenic promastigote populations to complement thus can-
not be ascribed to variations in their capacity to fix C3.
The number of CP-activated C3 molecules bound to sta-
tionary phase L. amazonensis, L. donovani, and C. fasciculata
promastigotes was calculated from Langmuir saturation
isotherm data. On a per cell basis, L. amazonensis promas-
tigotes bound 1.2   105, L. donovani 1.8   105, and C.
fasciculata 1.3   105 C3 molecules.
Real-time Kinetics of Leishmania Promastigote Lysis in
NHS. Promastigotes of four Leishmania species were ob-
tained from axenic cultures in log phase and the early sta-
tionary phase, and kinetic data on complement-mediated
lysis determined by measuring PI-stained cells. Dot plots
show real-time kinetics of log phase (Fig. 3 A, a–d) and
early stationary phase (Fig. 3 A, e–h) promastigote killing
in 50% NHS, as well as controls (Fig. 3 A, i–k). Log phase
Figure 2. Complement activation by
Leishmania in C1q- and C2-deficient sera.
Promastigotes were incubated in 50% PBS-
diluted NHS ( ), EGTA-NHS ( ),
C1qDS ( ), C2DS ( ), C1qDS supple-
mented with purified C1q ( ), or C2DS
supplemented with purified C2 ( ), and in-
cubated at 37 C for 0, 0.5, 3, 5, 7, and 10
min. Promastigote-bound C3 was then
measured with [125I]SIM27–49. Results are
expressed as a percentage of maximum
[125I]SIM27–49 binding. Each point repre-
sents the mean of duplicate samples. C1q-
and C2 factor-mediated C3 binding was
 5% of total C3 bound. (A) L. donovani;
(B) L. amazonensis.
Table I. Classical Complement Pathway Triggering of 
Promastigote-C3 Opsonization by Natural Anti-Leishmania 
Antibodies
Incubation Promastigote bound C3 (%)
30 s 120 s
L. amazonensis
(n)
L. donovani
(n)
PBS NHS 100 100
PBS NHS-EGTA 8.3   1.7 (4) 3.2   0.4 (4)
PBS IgM 2.8   1.2 (6) 3.0   1.4 (6)
PBS IgG 0.8   0.6 (3) 0.6   0.6 (4)
PBS Ads-NHS 15.1   2.0 (15) 11.4   1.1 (24)
NHS-EDTA NHS 100 100
NHS-EDTA Ads-NHS 88.8   4.8 (15) 71.7   5.3 (26)
IgM-EDTA Ads-NHS 88.6   2.7 (13) 93.8   3.6 (13)
IgG-EDTA Ads-NHS 17.8   1.4 (13) 17.4   2.9 (13)
Promastigote triggering of complement activation was analyzed in a
two-step binding assay. Promastigotes were preincubated (37 C, 30 s) in
100  l of PBS, NHS-EDTA, IgM-EDTA, or IgG-EDTA as indicated,
washed twice by centrifugation, and incubated (37 C, 120 s) in the
conditions indicated. Samples then were processed as described
(Materials and Methods). Results are expressed as the percentage of
maximum promastigote-bound C3 in NHS (100%)   SEM; (n),
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leishmania begin to incorporate PI within 30 s of serum
contact, and all cells are PI-labeled by 60 s (Fig. 3 B, top
panel). Log phase promastigotes are thus highly susceptible
to human complement. In contrast, PI uptake kinetics by
early stationary phase promastigotes is slower; it begins
within 30–60 s of serum contact, and is complete by  2.5
min (Fig. 3 B, bottom panel). Stationary phase promasti-
gotes show greater interspecies variability in PI uptake ki-
netics and percent killing (Fig. 3 B, bottom panel) than log
phase promastigotes. In stationary phase L. major and L. am-
azonensis promastigotes, 15 and 10% of the population, re-
spectively, show a degree of complement resistance (Fig. 3
A, e–f). The precise size of this population is difficult to
calculate as, in the presence of NHS, promastigote cell vol-
ume and refractile properties are altered, blurring the dis-
tinction between promastigotes, cell debris, and NHS
background signal. Stationary phase L. donovani and L. in-
fantum promastigotes appear to be more complement sus-
ceptible (Fig. 3 A, g and h), and no motile promastigotes
were observed under the microscope. Lysis of log and early
stationary phase promastigotes is gradual in all four species
(Fig. 3 A, a–g); the lytic mechanism differs for L. infantum
stationary phase promastigotes in that the entire promasti-
gote population undergoes sudden, simultaneous death,
with no intermediate stages (Fig. 3 A, h). These results in-
dicate that in NHS, Leishmania promastigote lysis is an ex-
tremely rapid reaction.
Discussion
To infect their hosts, Leishmania promastigotes must cir-
cumvent the cytolytic effects of complement. Identification
of the reaction mechanisms that govern promastigote op-
sonization could thus aid in comprehending Leishmania
evasion strategies of host innate immunity. The mechanism
of promastigote opsonization in NHS is the subject of con-
troversy; some data indicate that promastigotes activate
complement via the CP (2, 5, 6), but the dominant view is
that Leishmania activation of complement is antibody inde-
pendent, i.e., lectin- or AP-mediated (7–15). To elucidate
this mechanism, we studied four aspects of complement-
parasite interaction at near-physiological conditions, (a) the
Figure 3. Real-time kinetics of Leishmania promastigote lysis in NHS. Promastigotes were taken from log phase and early stationary phase growth cul-
tures, and the course of parasite lysis measured in 50% NHS as described (Materials and Methods). (A) FL2 against time dot plots of log phase (a–d), and
stationary phase (e–h) promastigote PI uptake in 50% NHS, as well as controls (i–k). L. major (a and e); L. amazonensis (b and f); L. donovani (c and g); L.
infantum (d and h); maximum PI uptake control (i); background PI uptake control in EDTA-NHS (j); and nonspecific NHS fluorescence (k). (B) Pro-
mastigote PI uptake kinetics derived from dot plot data. Top panel: log phase promastigotes. Lower panel: early stationary phase promastigotes. L. major
( ); L. amazonensis ( ); L. donovani ( ); L. infantum (*). 457 Dominguez et al.
kinetics of promastigote-C3 binding in NHS and in
EGTA-NHS, (b) the requirement for early CP factors for
C3 deposition, (c) the ability of anti-Leishmania NAb to
trigger C3 deposition in Ads-NHS, and (d) complement
leishmaniacidal activity by measuring the real-time kinetics
of promastigote killing.
In 25% NHS, promastigotes of all trypanosomatid spe-
cies studied activate classical and alternative complement
pathways simultaneously (Fig. 1). Promastigote-C3 deposi-
tion is extremely rapid; the reaction is complete after 2 to 3
min, at which time 86–93% of fixed C3 has been activated
through the CP. The contribution of the AP to promasti-
gote opsonization is much smaller, ranging from 7.1–13.7%.
Promastigote C3 binding is traditionally measured after 15
min incubation (9, 10) or longer (30–60 min) (7, 8, 11, 12,
28). CP C3 deposition can be detected only in a narrow
time window that lasts but a few minutes (Fig. 1); after this
time, classical and alternative pathway kinetics merge, and
only AP-dependent activity is observed. This may explain
why promastigote CP C3 deposition has passed unnoticed.
AP-mediated C3 deposition has a slower time course
than the CP (Fig. 1). In AP triggering, no specific recogni-
tion mechanism is involved, and both the kinetics and the
amount of C3 bound are directly related to the structure of
the promastigote surface. The AP pathway permits differ-
entiation of trypanosomatids by their C3 binding kinetics
and APt50 values, disclosing the large instraspecies variabil-
ity that exists within the subgenus Leishmania. Crithidia and
Leishmania are genetically more distant than amphibians
and mammals (29), yet larger AP kinetic differences are
found among Leishmania species than among parasites of
Leishmania, Crithidia and Phytomonas.
To identify the mechanism that triggers Leishmania op-
sonization in NHS, we used sera congenitally deficient in
C1q or C2 complement factors. Promastigote CP C3 bind-
ing kinetics in C1q- or C2-deficient sera is restored by ad-
dition of purified C1q or C2, respectively (Fig. 2); this re-
sult supports the involvement of early CP factors in
promastigote C3 opsonization. Parasite killing in C4- or
C2-deficient sera (8, 12), or in normal serum depleted of
natural anti-Leishmania antibodies (9, 11), has been taken as
proof that this reaction is AP mediated. In these studies,
earliest parasite lysis was measured after 15-min incubation,
when AP-mediated promastigote killing is fully active.
These experiments consequently provide no information
on the role of the CP in the lytic mechanism, for which
promastigote killing must be recorded in the early op-
sonization period (Fig. 1).
Candidate molecules in NHS to initiate parasite activa-
tion of the CP include anti-Leishmania NAb (2, 5, 6), MBL
(13), and CRP (14, 15). Complement triggering was ana-
lyzed in a two-stage incubation assay that measures the
ability of promastigote-bound IgM or IgG to initiate CP
activity in Ads-NHS; this preparation lacks the ability to
trigger CP C3 deposition. Promastigotes preincubated in
NHS-EDTA or IgM-EDTA bind natural IgM anti-Leish-
mania antibodies; after a second incubation in Ads-NHS,
they respectively deposit 88.8 and 88.6% of total C3 depos-
ited in NHS (Table I). In contrast, promastigotes preincu-
bated with IgG-EDTA fix only 17.8% of total C3 bound
(Table I). Triggering of CP C3 deposition by calcium-che-
lated NHS and protamine-isolated IgM fractions (Table I)
indicates that MBL and CRP do not participate in the re-
action, as their activity is calcium-dependent (14, 30). A
basic requirement for the physiological Leishmania op-
sonization mechanism in NHS is that C3 deposition must
be complete within 2–3 min of incubation at 37 C. MBL
and CRP are reported to bind to the Leishmania surface
(13–15), although these assays were done in far from physi-
ological conditions (1 h in the cold). Average human
plasma concentrations of MBL and CRP are 1,000-
( 10 10 M [31]) and 200-fold ( 0.5    10 9 M [14])
lower, respectively, than that of natural IgM anti-Leishma-
nia antibodies ( 1.6   10 7 M [2]). It thus appears un-
likely that they mediate the promastigote opsonization ki-
netics shown in Fig. 1. In chronic infections, MBL
concentrations can increase 2- to 3-fold (32) and those of
CRP up to 300-fold (33); MBL may thus act as an opsonin
(34) and modulate disease progression (35).
Given sufficient time and suitable temperature condi-
tions in vitro, Leishmania promastigotes can probably acti-
vate human complement via classical, alternative, and lectin
pathways. Under quasi-physiological conditions, however,
Leishmania opsonization is extremely rapid, and it is un-
likely that MBL or CRP can account for this mechanism.
We thus maintain that in NHS, natural IgM anti-Leishma-
nia antibodies are the main trigger of CP activation and
promastigote opsonization.
It has been proposed that parasite infective success relies
on their capacity to establish multiple interactions with host
cell receptors (36). The velocity of parasite opsonization
and the massive C3 deposition suggest that promastigote-
bound C3 has a pivotal role in the parasite–host interac-
tion. Leishmania C3 binding is a prerequisite for promasti-
gote IA (2, 3), receptor-mediated parasite binding to
macrophages and endocytosis (37–39), and intracellular
Leishmania survival (40). To correlate C3 deposition levels
with parasite infectivity, we analyzed promastigote-C3
binding during the L. amazonensis life cycle, and found that
promastigotes maintain a stable, CP-mediated C3 binding
capacity throughout in vitro metacyclogenenesis. Similar
data, although measuring AP-mediated C3 deposition,
have been reported for L. donovani, L. major, and L. ama-
zonensis (9–11), although others found higher C3 binding
to stationary promastigotes (37). Leishmania promastigotes
in axenic cultures are believed to recapitulate the develop-
mental sequence in the insect vector (41); promastigotes in
the vector gut may thus behave as do the axenic promasti-
gotes, and maintain invariant C3 binding capacity. Assum-
ing that promastigote-bound C3 is responsible for recep-
tor-mediated parasite binding to host cells and endocytosis,
it is plausible that all C3-opsonized promastigotes egested
from the sandfly gut into the blood pool have a similar
probability of invading host leukocytes. In this case, the
presence of infective metacyclic promastigotes would not
be a necessary condition for infectivity.458 Leishmania Opsonization in Human Serum
Despite the abundant literature on promastigote killing
by complement, time course studies of CP-mediated pro-
mastigote lysis at near-physiological conditions are lacking.
Here we show real-time kinetic analyses of this mechanism
(Fig. 3). Three aspects to be emphasized are the extreme
velocity of the promastigote lytic reaction, the striking sen-
sitivity of log phase Leishmania spp. populations to comple-
ment, and the differential complement susceptibility among
stationary phase Leishmania spp promastigote species. In all
four species tested, PI uptake by stationary phase promas-
tigotes begins within 30–60 s of serum contact and is com-
plete by 2.5 min (Fig. 3 B, bottom panel), confirming pre-
vious results (2). L. major promastigotes incorporate PI
more rapidly (Fig. 3 A, e), although this does not correlate
with greater complement sensitivity. Using flagellar motil-
ity as a viability criterion, 15% (L. major) and 10% (L. ama-
zonensis) of the promastigotes were viable after 2.5 min in
50% NHS. The data thus indicate that these species show a
degree of complement resistance, and support the idea (24)
that axenic Leishmania cultures give rise to developmental
parasite forms that are resistant to human complement
within the physiological infection period.
In contrast, L. donovani and L. infantum are highly sensi-
tive to complement, which is also the case for promasti-
gotes of all species tested in exponential growth (Fig. 3 B,
top panel). From these data, we estimate that from 85%
(stationary phase) to 100% (log phase) Leishmania spp. pro-
mastigotes are killed by complement after 2.5 min in hu-
man blood. To survive, Leishmania promastigotes must in-
vade host cells within this period. Assuming a sandfly blood
meal of 0.3  l, and sandfly thoracic midgut promastigote
body volume of 4  m3 (42), each sandfly bite would inoc-
ulate at most 75 parasites. Estimating that at least 90% will
be killed within 2.5 min, and that human blood phagocytes
engulf promastigotes at a granulocyte:monocyte ratio of
2:1, in each bite,  4% of promastigotes inoculated (5 pro-
mastigotes) would enter a safe monocyte haven. It is thus
clear that, during early stages of leishmaniosis transmission,
serum opsonins exert very strong selective pressure on
Leishmania, a mechanism that has presumably contributed
to shaping the parasite’s host evasion strategies.
Leishmania has been called a “parasite of paradox” for its
ability to dwell in macrophages, the cell committed to its
destruction (43); we would further justify this appellation.
Complement protects vertebrates against protozoan inva-
sion of the blood through the dual mechanisms of IA op-
sonic activity and the lytic cascade. Members of the Mu-
ridae family, such as the mouse and the hamster, have very
low complement lytic activity against Leishmania, and may
rely on IA opsonic activity to fend off infection (our un-
published data). In these genera, IA opsonic activity en-
hances promastigote phagocytosis and macrophage infec-
tion, which may explain the reservoir role of these rodents
for Leishmania. In contrast, humans have a strong comple-
ment system and a potent IA mechanism; after inocula-
tion, promastigote survival is linked to IA and endocytosis.
We suggest that appropriation of IA-mediated opsono-
phagocytosis is the principal Leishmania strategy to evade
the innate host response. Its capacity to transform the ver-
tebrate innate protective response into the key to host in-
vasion provides an additional motive for the sobriquet
“parasite of paradox.”
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